Latest: FDA Approves New Biosimilar for Oncology Treatment

Exa-cel Exhibits Meaningful HRQoL Benefit in Severe Sickle Cell Disease

0 Mins
The overall pain experience among adult and pediatric patients with severe sickle cell disease significantly improved after exa-cel infusion.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago